News
-
28 June 2018
KWF subsidy for fundamental research into incurable brain tumours
How does the most malignant form of brain cancer develop? That's what a Maastricht research group led by Prof. Marc Vooijs, PhD will study in mini tumours which they will 'grow' in their laboratory. The scientists will receive a €150.000 subsidy from the Dutch Cancer Society (KWF)...
-
21 June 2018
Breast reconstruction using fat tissue does not compromise oncological safety
Lipofilling, a breast reconstruction technique using the patient's own (autologous) fat tissue, does not compromise oncological safety or cause tumour cells to recur. These are the conclusions of a doctoral study conducted by researcher Todor Krastev, affiliated with the Plastic Surgery...
-
12 February 2018
Successful installation of cyclotron in proton therapy centre
On Saturday 10 February, the heart of the proton therapy centre - the cyclotron or particle accelerator - was lifted with military precision into the radiation bunker of the South-East Netherlands Proton Therapy Centre (ZON-PTC). A spectacle many people came to witness from a safe distance. The...
-
17 January 2018
Embryo selection for hereditary breast cancer successful
Performing preimplantation genetic diagnosis (PGD), or embryo selection, for hereditary breast cancer has proven to be successful, claims Inge Derks-Smeets of Maastricht UMC+ in her PhD research. Ten years after the first PGD procedure for hereditary breast cancer, the PhD student concludes that...
